Signaling mechanisms involved in disuse muscle atrophy

Medical Hypotheses

Volumn 69, Issue 2, 2007, Pages 310-321

  Zhang, Peng ^a   Chen, Xiaoping ^a   Fan, Ming ^b  

^a CHINA ASTRONAUT RESEARCH AND TRAINING CENTER   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; F BOX PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MUSCLE PROTEIN; MUSCLE RING FINGER 1; MYOSTATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); SOMATOMEDIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; BED REST; COMPLEX FORMATION; DENERVATION; DISEASE COURSE; FAST MUSCLE FIBER; GENE IDENTIFICATION; HINDLIMB; HUMAN; IMMOBILIZATION; INSULIN RESISTANCE; MICROGRAVITY; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SLOW MUSCLE FIBER;

HUMANS; MUSCULAR ATROPHY; SIGNAL TRANSDUCTION;

EID: 34249302084     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.11.043     Document Type: Article

References (78)

1. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294 (2001) 1704-1708
2. Gomes M.D., Lecker S.H., Jagoe R.T., Navon A., and Goldberg A.L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98 (2001) 14440-14445
3. Hershko A., and Ciechanover A. The ubiquitin system. Annu Rev Biochem 67 (1998) 425-479
4. Jackson P.K., and Eldridge A.G. The SCF ubiquitin ligase: an extended look. Mol Cell 9 (2002) 923-925
5. Centner T., Yano J., Kimura E., McElhinny A.S., Pelin K., Witt C.C., et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol 306 (2001) 717-726
6. Wray C.J., Mammen J.M., Hershko D.D., and Hasselgren P.O. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 35 (2003) 698-705
7. Latres E., Amini A.R., Amini A.A., Griffiths J., Martin F.J., Wei Y., et al. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280 (2005) 2737-2744
8. Li Y.P., Chen Y., John J., Moylan J., Jin B., Mann D.L., et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19 (2005) 362-370
9. Lecker S.H., Jagoe R.T., Gilbert A., Gomes M., Baracos V., Bailey J., et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18 (2004) 39-51
10. Tintignac L.A., Lagirand J., Batonnet S., Sirri V., Leibovitch M.P., and Leibovitch S.A. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem 280 (2005) 2847-2856
11. Glass D.J. Molecular mechanisms modulating muscle mass. Trends Mol Med 9 (2003) 344-350
12. Glass D.J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5 (2003) 87-90
13. Sartorelli V., and Fulco M. Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Sci STKE 2004 (2004) re11
14. Sacheck J.M., Ohtsuka A., McLary S.C., and Goldberg A.L. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287 (2004) E591-E601
15. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
16. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14 (2004) 395-403
17. Stevenson E.J., Giresi P.G., Koncarevic A., and Kandarian S.C. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 551 (2003) 33-48
18. Hornberger T.A., Hunter R.B., Kandarian S.C., and Esser K.A. Regulation of translation factors during hindlimb unloading and denervation of skeletal muscle in rats. Am J Physiol Cell Physiol 281 (2001) C179-C187
19. Chen W.S., Xu P.Z., Gottlob K., Chen M.L., Sokol K., Shiyanova T., et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15 (2001) 2203-2208
20. Peng X.D., Xu P.Z., Chen M.L., Hahn-Windgassen A., Skeen J., Jacobs J., et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17 (2003) 1352-1365
21. Tran H., Brunet A., Griffith E.C., and Greenberg M.E. The many forks in FOXO's road. Sci STKE 2003 (2003) RE5
22. Carlsson P., and Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol 250 (2002) 1-23
23. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
24. Ramaswamy S., Nakamura N., Sansal I., Bergeron L., and Sellers W.R. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2 (2002) 81-91
25. Kamei Y., Mizukami J., Miura S., Suzuki M., Takahashi N., Kawada T., et al. A forkhead transcription factor FKHR up-regulates lipoprotein lipase expression in skeletal muscle. FEBS Lett 536 (2003) 232-236
26. Kamei Y., Miura S., Suzuki M., Kai Y., Mizukami J., Taniguchi T., et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 279 (2004) 41114-41123
27. Bonizzi G., and Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 (2004) 280-288
28. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-κB system: a treasure trove for drug development. Nat RevDrug Discov 3 (2004) 17-26
29. Ladner K.J., Caligiuri M.A., and Guttridge D.C. Tumor necrosis factor-regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 278 (2003) 2294-2303
30. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., and Baldwin Jr. A.S. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289 (2000) 2363-2366
31. Kawamura I., Morishita R., Tomita N., Lacey E., Aketa M., Tsujimoto S., et al. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model. Gene Ther 6 (1999) 91-97
32. Li Y.P., and Reid M.B. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 279 (2000) R1165-R1170
33. Frenette J., Cai B., and Tidball J.G. Complement activation promotes muscle inflammation during modified muscle use. Am J Pathol 156 (2000) 2103-2110
34. Hunter R.B., Stevenson E., Koncarevic A., Mitchell-Felton H., Essig D.A., and Kandarian S.C. Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 16 (2002) 529-538
35. Hunter R.B., and Kandarian S.C. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 114 (2004) 1504-1511
36. Bar-Shai M., Carmeli E., Coleman R., Rozen N., Perek S., Fuchs D., et al. The effect of hindlimb immobilization on acid phosphatase, metalloproteinases and nuclear factor-kappaB in muscles of young and old rats. Mech Ageing Dev 126 (2005) 289-297
37. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189 (1999) 1839-1845
38. Cai D., Frantz J.D., Tawa Jr. N.E., Melendez P.A., Oh B.C., Lidov H.G., et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119 (2004) 285-298
39. Wyke S.M., Russel S.T., and Tisdale M.J. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. Br J Cancer 91 (2004) 1742-1750
40. Farid M., Reid M.B., Li Y.P., Gerken E., and Durham W.J. Effects of dietary curcumin or N-acetylcysteine on NF-kappaB activity and contractile performance in ambulatory and unloaded murine soleus. Nutr Metab (Lond) 2 (2005) 20
41. Li Y.P., Schwartz R.J., Waddell I.D., Holloway B.R., and Reid M.B. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor-alpha. FASEB J 12 (1998) 871-880
42. Kondo H., Miura M., and Itokawa Y. Oxidative stress in skeletal muscle atrophied by immobilization. Acta Physiol Scand 142 (1991) 527-528
43. Lawler J.M., Song W., and Demaree S.R. Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle. Free Radical Biol Med 35 (2003) 9-16
44. McPherron A.C., and Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94 (1997) 12457-12461
45. McPherron A.C., Lawler A.M., and Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387 (1997) 83-90
46. Kambadur R., Sharma M., Smith T.P., and Bass J.J. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 7 (1997) 910-916
47. Lee S.J., and McPherron A.C. Myostatin and the control of skeletal muscle mass. Curr Opin Genet Dev 9 (1999) 604-607
48. Lee S.J., and McPherron A.C. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98 (2001) 9306-9311
49. Nishi M., Yasue A., Nishimatu S., Nohno T., Yamaoka T., Itakura M., et al. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle. Biochem Biophys Res Commun 293 (2002) 247-251
50. Reisz-Porszasz S., Bhasin S., Artaza J.N., Shen R., Sinha-Hikim I., Hogue A., et al. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 285 (2003) E876-E888
51. Carlson C.J., Booth F.W., and Gordon S.E. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 277 (1999) R601-R606
52. Lalani R., Bhasin S., Byhower F., Tarnuzzer R., Grant M., Shen R., et al. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol 167 (2000) 417-428
53. Reardon K.A., Davis J., Kapsa R.M., Choong P., and Byrne E. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 24 (2001) 893-899
54. Wehling M., Cai B., and Tidball J.G. Modulation of myostatin expression during modified muscle use. FASEB J 14 (2000) 103-110
55. McMahon C.D., Popovic L., Oldham J.M., Jeanplong F., Smith H.K., Kambadur R., et al. Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 285 (2003) E82-E87
56. Ma K., Mallidis C., Bhasin S., Mahabadi V., Artaza J., Gonzalez-Cadavid N., et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285 (2003) E363-E371
57. Fang C.H., Li B.G., Tiao G., Wang J.J., Fischer J.E., and Hasselgren P.O. The molecular regulation of protein breakdown following burn injury is different in fast- and slow-twitch skeletal muscle. Int J Mol Med 1 (1998) 163-169
58. Tiao G., Lieberman M., Fischer J.E., and Hasselgren P.O. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am J Physiol 272 (1997) R849-R856
59. Li Y.P., Chen Y., Li A.S., and Reid M.B. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 285 (2003) C806-C812
60. Liu Y., Shen T., Randall W.R., and Schneider M.F. Signaling pathways in activity-dependent fiber type plasticity in adult skeletal muscle. J Muscle Res Cell Motil 26 (2005) 13-21
61. Childs T.E., Spangenburg E.E., Vyas D.R., and Booth F.W. Temporal alterations in protein signaling cascades during recovery from muscle atrophy. Am J Physiol Cell Physiol 285 (2003) C391-C398
62. Hirose M., Kaneki M., Sugita H., Yasuhara S., and Martyn J.A. Immobilization depresses insulin signaling in skeletal muscle. Am J Physiol Endocrinol Metab 279 (2000) E1235-E1241
63. Hilder T.L., Tou J.C., Grindeland R.E., Wade C.E., and Graves L.M. Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle. FEBS Lett 553 (2003) 63-67
64. Morris R.T., Spangenburg E.E., and Booth F.W. Responsiveness of cell signaling pathways during the failed 15-day regrowth of aged skeletal muscle. J Appl Physiol 96 (2004) 398-404
65. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature 420 (2000) 333-336
66. Klee C.B., Ren H., and Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273 (1998) 13367-13370
67. Olson E.N., and Williams R.S. Remodeling muscles with calcineurin. Bioessays 22 (2000) 510-519
68. Wu H., Rothermel B., Kanatous S., Rosenberg P., Naya F.J., Shelton J.M., et al. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 20 (2001) 6414-6423
69. Shen T., Liu Y., Cseresnyes Z., Hawkins A., Randall W.R., and Schneider M.F. Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers. Mol Biol Cell 17 (2006) 1570-1582
70. Naya F.J., Mercer B., Shelton J., Richardson J.A., Williams R.S., and Olson E.N. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem 275 (2000) 4545-4548
71. McCullagh K.J., Calabria E., Pallafacchina G., Ciciliot S., Serrano A.L., and Argentini C. NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching. Proc Natl Acad Sci USA 101 (2004) 10590-10595
72. Musaro A., McCullagh K.J., Naya F.J., Olson E.N., and Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400 (1999) 581-585
73. 2+-dependent calcineurin signalling pathway. Nature 400 (1999) 576-581
74. Dupont-Versteegden E.E., Knox M., Gurley C.M., Houle J.D., and Peterson C.A. Maintenance of muscle mass is not dependent on the calcineurin-NFAT pathway. Am J Physiol Cell Physiol 282 (2002) C1387-C1395
75. Furukawa-Hibi Y., Yoshida-Araki K., Ohta T., Ikeda K., and Motoyama N. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem 277 (2002) 26729-26732
76. Dupont-Versteegden E.E., Strotman B.A., Gurley C.M., Gaddy D., Knox M., Fluckey J.D., et al. Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei. Am J Physiol Regul Integr Comp Physiol 291 (2006) R1730-R1740
77. Allen D.L., and Unterman T.G. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 292 (2006) C188-C199
78. Kell R., Pierce H., and Swoap S.J. PGAM-M expression is regulated pretranslationally in hindlimb muscles and under altered loading conditions. J Appl Physiol 86 (1999) 236-242